Beihai Gofar Chuanshan Biological Past Earnings Performance
Past criteria checks 0/6
Beihai Gofar Chuanshan Biological's earnings have been declining at an average annual rate of -16.7%, while the Chemicals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 13.4% per year.
Key information
-16.7%
Earnings growth rate
-8.6%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 13.4% |
| Return on equity | -10.5% |
| Net Margin | -25.9% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Beihai Gofar Chuanshan Biological makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 355 | -92 | 97 | 13 |
| 31 Dec 23 | 369 | -82 | 95 | 13 |
| 30 Sep 23 | 405 | -14 | 95 | 8 |
| 30 Jun 23 | 435 | 16 | 94 | 8 |
| 31 Mar 23 | 440 | 25 | 93 | 8 |
| 31 Dec 22 | 460 | 35 | 91 | 8 |
| 30 Sep 22 | 459 | 36 | 86 | 10 |
| 30 Jun 22 | 454 | 15 | 85 | 10 |
| 31 Mar 22 | 452 | 14 | 84 | 9 |
| 31 Dec 21 | 425 | 10 | 86 | 9 |
| 30 Sep 21 | 391 | 16 | 79 | 5 |
| 30 Jun 21 | 340 | 12 | 73 | 3 |
| 31 Mar 21 | 303 | 6 | 68 | 2 |
| 31 Dec 20 | 268 | 3 | 61 | 0 |
| 30 Sep 20 | 249 | 7 | 58 | 0 |
| 30 Jun 20 | 257 | 7 | 58 | 0 |
| 31 Mar 20 | 254 | 5 | 56 | 0 |
| 31 Dec 19 | 251 | 6 | 57 | 0 |
| 30 Sep 19 | 245 | -22 | 69 | 0 |
| 30 Jun 19 | 234 | -21 | 66 | 0 |
| 31 Mar 19 | 232 | -20 | 69 | 0 |
| 31 Dec 18 | 225 | -22 | 69 | 0 |
| 30 Sep 18 | 88 | 11 | 30 | -1 |
| 30 Jun 18 | 148 | 15 | 39 | 0 |
| 31 Mar 18 | 173 | 10 | 42 | 0 |
| 31 Dec 17 | 232 | 7 | 46 | 0 |
| 30 Sep 17 | 240 | 13 | 55 | 1 |
| 30 Jun 17 | 218 | 2 | 54 | 0 |
| 31 Mar 17 | 268 | 6 | 57 | 0 |
| 31 Dec 16 | 263 | 3 | 63 | 0 |
| 30 Sep 16 | 481 | -12 | 88 | 0 |
| 30 Jun 16 | 499 | -9 | 89 | 0 |
| 31 Mar 16 | 490 | 1 | 82 | 0 |
| 31 Dec 15 | 506 | 4 | 79 | 0 |
| 30 Sep 15 | 460 | -32 | 86 | 0 |
| 30 Jun 15 | 440 | -34 | 85 | 0 |
| 31 Mar 15 | 440 | -48 | 86 | 0 |
| 31 Dec 14 | 415 | -49 | 85 | 0 |
| 30 Sep 14 | 419 | 2 | 80 | 0 |
| 30 Jun 14 | 412 | 4 | 78 | 0 |
| 31 Mar 14 | 415 | 8 | 79 | 0 |
| 31 Dec 13 | 452 | 11 | 79 | 0 |
| 30 Sep 13 | 458 | -91 | 106 | 0 |
| 30 Jun 13 | 503 | -99 | 117 | 0 |
Quality Earnings: 600538 is currently unprofitable.
Growing Profit Margin: 600538 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 600538 is unprofitable, and losses have increased over the past 5 years at a rate of 16.7% per year.
Accelerating Growth: Unable to compare 600538's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 600538 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.5%).
Return on Equity
High ROE: 600538 has a negative Return on Equity (-10.46%), as it is currently unprofitable.